IRIS
D'ANGELO, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.071
AS - Asia 5.789
EU - Europa 4.634
SA - Sud America 879
AF - Africa 214
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.927
CN - Cina 2.938
SG - Singapore 1.246
IE - Irlanda 1.074
BR - Brasile 676
DE - Germania 665
UA - Ucraina 642
FI - Finlandia 578
HK - Hong Kong 559
RU - Federazione Russa 487
VN - Vietnam 485
FR - Francia 279
SE - Svezia 240
IT - Italia 235
GB - Regno Unito 233
IN - India 142
ZA - Sudafrica 125
CA - Canada 81
BD - Bangladesh 76
AR - Argentina 73
IQ - Iraq 43
JP - Giappone 43
ID - Indonesia 42
TR - Turchia 39
MX - Messico 35
NL - Olanda 32
BE - Belgio 30
ES - Italia 29
EC - Ecuador 28
PK - Pakistan 26
PL - Polonia 23
CO - Colombia 22
UZ - Uzbekistan 21
VE - Venezuela 21
PH - Filippine 20
PE - Perù 18
JO - Giordania 17
EG - Egitto 16
PY - Paraguay 15
TN - Tunisia 15
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
MA - Marocco 13
MY - Malesia 13
BO - Bolivia 11
CL - Cile 10
AT - Austria 9
LT - Lituania 9
CR - Costa Rica 8
IL - Israele 8
KZ - Kazakistan 8
MU - Mauritius 8
AE - Emirati Arabi Uniti 7
KE - Kenya 6
RO - Romania 6
AZ - Azerbaigian 5
CH - Svizzera 5
ET - Etiopia 5
MK - Macedonia 5
NP - Nepal 5
SN - Senegal 5
AL - Albania 4
DZ - Algeria 4
HU - Ungheria 4
JM - Giamaica 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AM - Armenia 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
MG - Madagascar 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
TH - Thailandia 3
UY - Uruguay 3
BG - Bulgaria 2
BH - Bahrain 2
DJ - Gibuti 2
EE - Estonia 2
GA - Gabon 2
IS - Islanda 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
NC - Nuova Caledonia 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
AO - Angola 1
Totale 18.574
Salva come PNG Salva come JPEG
Città #
Dublin 1.074
Chandler 894
Jacksonville 848
San Jose 706
Nanjing 655
Singapore 638
Hong Kong 545
Dallas 541
Ashburn 526
Beijing 418
Boardman 327
Nanchang 287
Munich 204
Shenyang 201
Princeton 194
Lauterbourg 190
Lawrence 190
Medford 186
Helsinki 185
Hebei 180
Ho Chi Minh City 173
Wilmington 173
Changsha 171
Los Angeles 170
Jiaxing 162
Hanoi 118
Johannesburg 114
Hangzhou 110
Tianjin 102
Ann Arbor 90
Redondo Beach 88
Moscow 86
Buffalo 84
Shanghai 78
São Paulo 72
New York 70
Orem 55
Woodbridge 53
Santa Clara 52
Cambridge 51
Turku 50
Milan 44
Toronto 41
Seattle 40
Tokyo 37
Chennai 34
Piscataway 32
Pavia 28
Brussels 27
Fairfield 26
Montreal 26
Pune 26
Rio de Janeiro 26
Des Moines 25
Frankfurt am Main 25
Norwalk 24
Jinan 22
Brooklyn 21
Kunming 21
Baghdad 20
Da Nang 20
San Francisco 20
Stockholm 20
Guangzhou 19
Haiphong 19
London 18
Tashkent 18
The Dalles 18
Chicago 17
Verona 17
Ankara 15
Atlanta 15
Belo Horizonte 15
Boston 14
Falkenstein 14
Quito 14
Warsaw 14
Amman 13
Campinas 13
Denver 13
Dhaka 13
Charlotte 12
Houston 12
Phoenix 12
Taizhou 12
Zhengzhou 12
Bắc Ninh 11
Manchester 11
Ningbo 11
Orange 11
Poplar 11
Washington 11
Curitiba 10
Salvador 10
Amsterdam 9
Biên Hòa 9
Brasília 9
Hải Dương 9
Jakarta 9
Porto Alegre 9
Totale 12.195
Salva come PNG Salva come JPEG
Nome #
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 242
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 182
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 162
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 155
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 154
Effect of Diazepam on 24-Hour Blood Pressure and Heart Rate in Healthy Young Volunteers 149
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 143
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 140
Abscisic Acid Treatment in Patients with Prediabetes. 139
RAGE : a central player in nondiabetic vascular disease 136
The Apolipoprotein(a) Component of Lipoprotein(a) Mediates Binding to Laminin: Contribution to Selective Retention of Lipoprotein(a) in Atherosclerotic Lesions 136
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 135
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 129
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 129
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 129
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 128
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 128
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 128
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 127
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 125
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 124
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 123
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 123
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 121
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 120
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 120
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 119
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 119
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 118
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 117
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 116
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 116
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 115
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 115
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 115
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 115
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia 114
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 114
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 114
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 112
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 111
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 111
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 110
Effect of flunitrazepam as an oral hypnotic on 24-hour blood pressure in healthy volunteers. 109
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients 109
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 108
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 107
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 107
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients 107
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 106
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 106
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 106
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 105
Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients 105
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 104
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 104
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 103
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 103
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. 103
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 103
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 103
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 102
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 102
Low plasma apelin levels predict arrhythmia recurrence in patients with persistent atrial fibrillation 102
Action of L-acetylcarnitine on different cerebral mitochondrial populations from cerebral cortex 102
Benzodiazepins and cardiovascular risk: recent acquisitions and revision of literature. 102
Effetti dell'associazione tra pioglitazone e sibutramina sul metabolismo glucidico e lipidico nei soggetti obesi diabetici di tipo 2 101
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 101
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 100
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 100
Le metalloprotesi -2 e -9 e i loro inibitori tissutali -1 e -2 nei soggetti sani e nei soggetti con diabete di tipo 2 100
Effects of oral administration of alprazolam and lorazepam as hypnotics on cardiovascular parameters in hypertensive patients. 100
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 99
Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex 99
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 98
Diazepam as an oral hypnotic increases nocturnal blood pressure in the elderly. 98
Effetti metabolici di telmisartan e irbesartan nei apzienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 97
Effects of berberine on lipid profile in subjects with low cardiovascular risk 97
MMP-2, -9 and TIMP-1 in patients with hypertension before and after doxazosin therapy 96
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 95
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 95
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 93
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 93
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 91
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 91
A role for quercetin in coronavirus disease 2019 (COVID-19) 90
Candesartan effect on inflammation in hypertension 90
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome 90
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 89
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 89
Matrix metalloproteinases and tissue inhibitor metalloproteinases in hypertensive patients 88
Efficacia e sicurezza di pioglitazone o rosiglitazone in combinazione con metformina in pazienti con diabete di tipo 2 e sindrome metabolica 88
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance 88
A randomized, double-blind, placebo-controlled study to evaluate the effectiveness of a food supplement containing creatine and d-ribose combined with a physical exercise program in increasing stress tolerance in patients with ischemic heart disease 87
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone 87
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus 87
Effetti di sitagliptin o metformina associati a pioglitazone in pazienti diabetici scarsamente controllati 86
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus 86
Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy. 86
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients 86
Totale 11.147
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021385 0 0 0 0 0 0 0 0 0 186 157 42
2021/2022740 12 4 30 5 6 10 5 46 44 15 119 444
2022/20232.855 286 200 20 189 282 283 2 163 1.253 35 89 53
2023/2024964 110 179 27 57 87 223 3 100 9 39 61 69
2024/20252.899 28 235 88 73 57 145 234 240 688 87 315 709
2025/20266.135 551 420 831 714 730 272 1.336 305 581 395 0 0
Totale 18.828